Cargando…
Comparison of long‐term clinical outcomes in multivessel coronary artery disease patients treated either with bioresoarbable polymer sirolimus‐eluting stent or permanent polymer everolimus‐eluting stent: 5‐year results of the CENTURY II randomized clinical trial
OBJECTIVES: To assess the long‐term safety and efficacy of a sirolimus‐eluting stent with bioresorbable polymer (BP‐SES; Ultimaster), in comparison to a benchmark everolimus‐eluting, permanent polymer stent (PP‐EES; Xience), in a prespecified subgroup of patients with multivessel coronary artery dis...
Autores principales: | Iñiguez, Andrés, Chevalier, Bernard, Richardt, Gert, Neylon, Antoinette, Jiménez, Victor A., Kornowski, Ran, Carrie, Didier, Moreno, Raul, Barbato, Emanuele, Serra‐Peñaranda, Antoni, Guiducci, Vincenzo, Valdés‐Chávarri, Mariano, Yajima, Junji, Wijns, William, Saito, Shigeru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7064960/ https://www.ncbi.nlm.nih.gov/pubmed/31033154 http://dx.doi.org/10.1002/ccd.28224 |
Ejemplares similares
-
Individual patient data analysis of the BIOFLOW study program comparing safety and efficacy of a bioresorbable polymer sirolimus eluting stent to a durable polymer everolimus eluting stent
por: Toelg, Ralph, et al.
Publicado: (2020) -
Elastic stent recoil in coronary total occlusions: Comparison of durable‐polymer zotarolimus eluting stent and ultrathin strut bioabsorbable‐polymer sirolimus eluting stent
por: Improta, Riccardo, et al.
Publicado: (2021) -
Comparison of neointimal coverage between ultrathin biodegradable polymer‐coated sirolimus‐eluting stents and durable polymer‐coated everolimus‐eluting stents: 6 months optical coherence tomography follow‐up from the TAXCO study
por: Abhyankar, Atul, et al.
Publicado: (2020) -
Three‐year clinical outcome of biodegradable hybrid polymer Orsiro sirolimus‐eluting stent and the durable biocompatible polymer Resolute Integrity zotarolimus‐eluting stent: A randomized controlled trial
por: Kim, Soo‐Hyun, et al.
Publicado: (2019) -
Impact of diabetes on clinical outcomes after revascularization with the dual therapy CD34 antibody‐covered sirolimus‐eluting Combo stent and the sirolimus‐eluting Orsiro stent
por: Jakobsen, Lars, et al.
Publicado: (2022)